Sanofi and Verily Life Sciences team up for digital diabetes solution

Collaboration aims to help people with diabetes live full, healthy lives.

Life sciences companies Sanofi  and Verily Life Sciences have announced the launch of Onduo, a diabetes-focused collaboration. The project aims to help people with diabetes to manage their conditions and live full, healthy lives using devices, software, medicine and professional care.

Onduo chief executive officer, Joshua Riff said:

"My experience as a physician and in leading consumer health initiatives has shown me the daily burden of living with diabetes," said Dr. Riff. "From monitoring food intake to testing glucose levels to actively seeking medical care, the challenges both on the physical and mental well-being of a person living with diabetes are incredibly difficult. We want to develop solutions that allow people living with diabetes to focus on the things they love and enjoy in life by providing tools to make dealing with their diabetes less burdensome."

Onduo will focus on the type 2 diabetes community, specifically on developing solutions that could help people make better decisions about their day-to-day health, ranging from improved medication management to improved habits and goals. Onduo aims to expand its focus to type 1 diabetes, and eventually to people at risk of developing diabetes with the goal of helping them better prevent the onset of the disease.